SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $748.50 million. The enterprise value is $639.16 million.
Important Dates
The next estimated earnings date is Monday, February 23, 2026, after market close.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 43.39 million shares outstanding. The number of shares has increased by 3.43% in one year.
| Current Share Class | 43.39M |
| Shares Outstanding | 43.39M |
| Shares Change (YoY) | +3.43% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 2.96% |
| Owned by Institutions (%) | 100.04% |
| Float | 39.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| Forward PS | 3.34 |
| PB Ratio | 4.27 |
| P/TBV Ratio | 4.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.97, with a Debt / Equity ratio of 0.21.
| Current Ratio | 7.97 |
| Quick Ratio | 6.53 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.09 |
Financial Efficiency
Return on equity (ROE) is -12.91% and return on invested capital (ROIC) is -7.69%.
| Return on Equity (ROE) | -12.91% |
| Return on Assets (ROA) | -6.87% |
| Return on Invested Capital (ROIC) | -7.69% |
| Return on Capital Employed (ROCE) | -12.20% |
| Revenue Per Employee | $554,665 |
| Profits Per Employee | -$62,335 |
| Employee Count | 349 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.58% in the last 52 weeks. The beta is 0.70, so SI-BONE's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -0.58% |
| 50-Day Moving Average | 18.98 |
| 200-Day Moving Average | 16.96 |
| Relative Strength Index (RSI) | 35.86 |
| Average Volume (20 Days) | 513,014 |
Short Selling Information
The latest short interest is 2.43 million, so 5.60% of the outstanding shares have been sold short.
| Short Interest | 2.43M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 5.60% |
| Short % of Float | 6.15% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, SI-BONE had revenue of $193.58 million and -$21.76 million in losses. Loss per share was -$0.51.
| Revenue | 193.58M |
| Gross Profit | 154.13M |
| Operating Income | -25.36M |
| Pretax Income | -21.76M |
| Net Income | -21.76M |
| EBITDA | -20.02M |
| EBIT | -25.36M |
| Loss Per Share | -$0.51 |
Full Income StatementBalance Sheet
The company has $145.74 million in cash and $36.84 million in debt, with a net cash position of $108.91 million or $2.51 per share.
| Cash & Cash Equivalents | 145.74M |
| Total Debt | 36.84M |
| Net Cash | 108.91M |
| Net Cash Per Share | $2.51 |
| Equity (Book Value) | 172.13M |
| Book Value Per Share | 3.98 |
| Working Capital | 184.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.23 million and capital expenditures -$9.39 million, giving a free cash flow of -$10.62 million.
| Operating Cash Flow | -1.23M |
| Capital Expenditures | -9.39M |
| Free Cash Flow | -10.62M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
Gross margin is 79.62%, with operating and profit margins of -13.10% and -11.24%.
| Gross Margin | 79.62% |
| Operating Margin | -13.10% |
| Pretax Margin | -11.24% |
| Profit Margin | -11.24% |
| EBITDA Margin | -10.34% |
| EBIT Margin | -13.10% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.43% |
| Shareholder Yield | -3.43% |
| Earnings Yield | -2.91% |
| FCF Yield | -1.42% |
Analyst Forecast
The average price target for SI-BONE is $25.57, which is 48.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.57 |
| Price Target Difference | 48.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 16.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.12 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 4 |
